Synapse - Works

Results (13087)

Initial phase II experience of ipilimumab (IPI) alone and in combination with radiotherapy (XRT) in patients with metastatic castration-resistant prostate cancer (mCRPC)

Meeting Abstract

Slovin, S. F.; Beer, T. M.; Higano, C. S.; Tejwani, S.; Hamid, O.; Picus, J.; Harzstark, A.; Scher, H. I.; Lan, Z.; Lowy, I.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Characteristics of first relapse in stage III melanoma patients with no evidence of disease (NED): Guidelines for follow-up

Meeting Abstract

Romano, E.; Scordo, M.; Chapman, P.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Prognostic value of quantitative image analysis (QIA) for determination of proliferative index in mantle cell lymphoma (MCL) treated with sequential chemotherapy followed by high-dose therapy and autologous stem cell rescue (HDT/ASCR)

Meeting Abstract

Schaffel, R.; Hedvat, C.; Teruya-Feldstein, J.; Portlock, C. S.; Moskowitz, C. H.; Zelenetz, A. D.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

FDG PET/CT (FDG PET) in evaluation of response in patients with multiple myeloma (MM) treated with bortezomib, pegylated liposomal doxorubicin, and dexamethasone

Meeting Abstract

Pandit-Taskar, N.; Comenzo, R. L.; Hassoun, H.; Hoover, E.; Borkar, S.; Reidel, E.; Cohen, A.; Surti, C.; Nimer, S. D.; Landau, H. J.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Phase I/II study of docetaxel and (153)Sm for castrate metastatic prostate cancer (CMPC): Summary of dose-escalation cohorts and first report on the expansion cohort

Meeting Abstract

Morris, M. J.; Pandit-Taskar, N.; Stephenson, R. D.; Hong, C.; Slovin, S. F.; Rathkopf, D.; Solit, D.; Carrasquillo, J.; Larson, S.; Scher, H. I.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Evaluation of the role of aromatase inhibitors (AIs) in the treatment of uterine leiomyosarcoma (uLMS)

Meeting Abstract

O'Cearbhaill, R.; Zhou, Q.; Iasonos, A.; Soslow, R. A.; Leitao, M. M. Jr; Aghajanian, C. A.; Hensley, M. L.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

PROPEL: Results of the pivotal, multicenter, phase II study of pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL)

Meeting Abstract

O'Connor, O.; Pro, B.; Pinter-Brown, L.; Popplewell, L.; Bartlett, N.; Lechowicz, M.; Savage, K.; Coiffier, B.; Saunders, M.; Horwitz, S.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Late mortality and morbidity of patients with Hodgkin lymphoma treated in adulthood

Meeting Abstract

Matasar, M. J.; McCallen, L. N.; Riedel, E. R.; Ford, J. S.; Oeffinger, K. C.; Straus, D. J.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Increased expression of androgen receptor (AR) and enzymes involved in androgen synthesis in metastatic prostate cancer: Targets for novel personalized therapies

Meeting Abstract

Mitsiades, N.; Schultz, N.; Taylor, B. S.; Hieronymus, H.; Satagopan, J.; Scardino, P. T.; Reuter, V. E.; Sander, C.; Sawyers, C.; Scher, H. I.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in patients with light-chain amyloidosis (AL)

Meeting Abstract

Landau, H. J.; Hoffman, J.; Hassoun, H.; Elizabeth, H.; Riedel, E.; Nimer, S. D.; Cohen, A.; Comenzo, R. L.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save